Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2.50 at Jefferies
Tweet Send to a Friend
Jefferies analyst Akash Tewari lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $2.50 (from $6.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
